Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
49.10
+1.43 (3.00%)
Nov 22, 2024, 4:00 PM EST - Market closed

Cytokinetics Stock Forecast

Stock Price Forecast

The 15 analysts with 12-month price forecasts for Cytokinetics stock have an average target of 83.67, with a low estimate of 60 and a high estimate of 120. The average target predicts an increase of 70.41% from the current stock price of 49.10.

Analyst Consensus: Buy
Target Low Average Median High
Price $60 $83.67 $80 $120
Change +22.20% +70.41% +62.93% +144.40%

Analyst Ratings

The average analyst rating for Cytokinetics stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 665555
Buy 777667
Hold 334444
Sell 000000
Strong Sell 000000
Total 161616151516

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Needham
Needham
Strong Buy
Reiterates
$72
Strong Buy Reiterates $72 +46.64% Nov 20, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$120
Strong Buy Reiterates $120 +144.40% Nov 19, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$120
Strong Buy Reiterates $120 +144.40% Nov 18, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$120
Strong Buy Reiterates $120 +144.40% Nov 11, 2024
RBC Capital
RBC Capital
Buy
Initiates
$80
Buy Initiates $80 +62.93% Nov 8, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
6.55M
from 7.53M
Decreased by -12.99%
Revenue Next Year
66.27M
from 6.55M
Increased by 911.39%
EPS This Year
-5.37
from -5.45
EPS Next Year
-5.33
from -5.37
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
26.87M55.83M70.43M94.59M7.53M6.55M66.27M351.47M
Revenue Growth
-14.71%107.79%26.15%34.30%-92.04%-12.99%911.39%430.39%
EPS
-2.11-1.97-2.80-4.33-5.45-5.37-5.33-3.65
EPS Growth
--------
Forward PE
--------
No. Analysts -----201916
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 44.2M 237.2M 578.5M
Avg 6.6M 66.3M 351.5M
Low 1.1M 15.7M 200.3M

Revenue Growth

Revenue Growth 20242025202620272028
High
487.2%
3,520.3%
772.9%
Avg
-13.0%
911.4%
430.4%
Low
-85.7%
139.3%
202.3%

EPS Forecast

EPS 20242025202620272028
High -5.17 -3.68 -1.52
Avg -5.37 -5.33 -3.65
Low -5.48 -6.58 -5.67

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.